chr2-178621863-G-T
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001267550.2(TTN):c.45059C>A(p.Thr15020Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,611,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
 Genomes: 𝑓 0.000026   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.000025   (  0   hom.  ) 
Consequence
 TTN
NM_001267550.2 missense
NM_001267550.2 missense
Scores
 5
 4
 8
Clinical Significance
Conservation
 PhyloP100:  7.95  
Publications
1 publications found 
Genes affected
 TTN  (HGNC:12403):  (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.2402581). 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TTN | NM_001267550.2  | c.45059C>A | p.Thr15020Asn | missense_variant | Exon 244 of 363 | ENST00000589042.5 | NP_001254479.2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TTN | ENST00000589042.5  | c.45059C>A | p.Thr15020Asn | missense_variant | Exon 244 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 | 
Frequencies
GnomAD3 genomes   AF:  0.0000263  AC: 4AN: 151920Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
4
AN: 
151920
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000525  AC: 13AN: 247568 AF XY:  0.0000596   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
13
AN: 
247568
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000253  AC: 37AN: 1460070Hom.:  0  Cov.: 32 AF XY:  0.0000386  AC XY: 28AN XY: 726304 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
37
AN: 
1460070
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
28
AN XY: 
726304
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33400
American (AMR) 
 AF: 
AC: 
0
AN: 
44578
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26070
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39476
South Asian (SAS) 
 AF: 
AC: 
34
AN: 
86158
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53338
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5752
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1111034
Other (OTH) 
 AF: 
AC: 
3
AN: 
60264
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.452 
Heterozygous variant carriers
 0 
 3 
 6 
 10 
 13 
 16 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0000263  AC: 4AN: 151920Hom.:  0  Cov.: 33 AF XY:  0.0000270  AC XY: 2AN XY: 74172 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
4
AN: 
151920
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
2
AN XY: 
74172
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
41408
American (AMR) 
 AF: 
AC: 
0
AN: 
15220
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5136
South Asian (SAS) 
 AF: 
AC: 
3
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10618
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
67928
Other (OTH) 
 AF: 
AC: 
0
AN: 
2088
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.438 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ExAC 
 AF: 
AC: 
8
Asia WGS 
 AF: 
AC: 
4
AN: 
3478
ClinVar
Significance: Uncertain significance 
Submissions summary: Uncertain:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Uncertain:1 
Jun 19, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Uncertain:1 
Apr 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Pathogenic 
 BayesDel_addAF 
 Benign 
T 
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Pathogenic 
 FATHMM_MKL 
 Pathogenic 
D 
 LIST_S2 
 Uncertain 
D;D;D;.;D;D;D 
 M_CAP 
 Benign 
D 
 MetaRNN 
 Benign 
T;T;T;T;T;T;T 
 MetaSVM 
 Benign 
T 
 MutationAssessor 
 Pathogenic 
.;.;.;H;.;.;H 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Uncertain 
D;D;.;.;D;D;. 
 REVEL 
 Uncertain 
 Sift 
 Benign 
T;T;.;.;T;T;. 
 Polyphen 
 0.96 
.;.;.;D;.;.;D 
 Vest4 
 MutPred 
 0.53 
.;.;.;Loss of glycosylation at S13380 (P = 0.0944);.;.;Loss of glycosylation at S13380 (P = 0.0944);
 MVP 
 MPC 
 0.37 
 ClinPred 
T 
 GERP RS 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.